Lab Sciences
Top stories summarized by our editors
10/19/2018

Since Aug. 1, at least 223 confirmed cases of Ebola have been documented in an outbreak of the virus in the Democratic Republic of Congo, and at least 144 people have died. Public health workers have struggled in some cases to implement preventive measures, and researchers are especially concerned about a disproportionate number of infections seen in children, who accounted for 60% of newly reported cases in the first two weeks of October around the current epicenter of disease.

10/19/2018

A retraction was issued by the New England Journal of Medicine for a 2011 paper titled "Evidence for Human Lung Stem Cells," co-authored by Dr. Piero Anversa, cardiac stem cell proponent and former Harvard University professor, and the journal also published an "expression of concern" concerning two other studies. The retraction was made because of evidence that some images included in the paper had been manipulated.

10/18/2018

The devastating effects of Zika virus are becoming evident as those born with related defects in Brazil grow older, and now more cases of microcephaly are surfacing among infants in Angola. The data emphasize the need for funding for continuous surveillance, monitoring and prevention of the disease, as well as the need for improved diagnostics and birth defect monitoring programs.

Full Story:
Reuters, Reuters
More Summaries:
microcephaly, Zika
10/18/2018

The World Health Organization declared that the Democratic Republic of Congo's current Ebola outbreak does not constitute a global public health emergency. WHO leaders did call for an escalated response, including more support from UN peacekeeping forces, to halt the virus' spread.

10/18/2018

Research led by Oregon Health & Science University scientists has yielded the largest acute myeloid leukemia dataset yet, consisting of 672 samples from 562 patients, and they hope the work will lead to new advances in AML care. The team developed a novel data visualization system known as Vizome to organize the information, and the work is described in the journal Nature.

10/18/2018

A National Cancer Patient Experience Survey in the UK showed that 59% of patients with hematologic cancers said they fully understood their diagnosis after receiving it, substantially less than for skin, prostate and colorectal cancers. "If people do not understand their diagnosis, then they are not in a position to ask informed questions about their condition or to explain their disease to their loved ones," said Sarah Porch of the British charity Bloodwise.

Full Story:
Myeloma Research News
10/17/2018

Zipline currently meets 30% of Rwanda's national demand for emergency transfusions by delivering blood and other supplies to outlying clinics via drone, and an expanded agreement will allow the company to supply the rest of the country. Zipline is testing a similar system in Ghana and working on a pilot project in North Carolina as well.

10/17/2018

Spanish researchers assessed reservoir reductions in 23 patients with HIV-1 infections and high-risk hematologic disease who had been treated with antiretroviral therapy and allogeneic hematopoietic stem cell transplant. Findings published in the journal Annals of Internal Medicine indicated that allo-HSCT induces long-term reduction in detectable HIV with ongoing ART.

More Summaries:
hematologic disease, HIV
10/17/2018

The American Red Cross has partnered with the Sickle Cell Disease Association of America and the Sickle Cell Foundation of Georgia on a five-year collaboration to promote blood donation, particularly among African-Americans, among whom SCD is common.

10/16/2018

Thirty-one papers from the lab of Dr. Piero Anversa, whose work explored use of cardiac stem cells for regeneration of heart tissue, contain "falsified and/or fabricated data" and should be retracted, according to Harvard Medical School and Brigham and Women's Hospital. Anversa had said the heart contains stem cells known as c-kit cells, but efforts to reproduce his findings failed, and studies that tested injection of c-kit cells into ailing hearts yielded mixed results.